Earnings Call · Q1 FY2023·2023-05-13

Q1 23EPS -12.50%·Rev n/aQ4 22EPS -41.67%·Rev n/aQ3 22EPS +78.26%·Rev n/aQ2 22EPS +42.86%·Rev n/a⚠ consensus missing

Anika Therapeutics, Inc. ANIK

−2.7%1d on move date−2.2% vs SPY3d−2.6%5d−1.1%

Research tier

Behavioral profile computed for this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more ANIK calls or request research access.

More ANIK calls Browse calls Request research access